Sprott
SII
115.32
-4.09
-3.43%
Sprott
US · SII
#2511 by market cap
Listed 1970
115.32
-4.09
-3.43%
Live - 5344 symbols - heartbeat 470s ago
· 2026-10-07 19:54
After-hours
115.32
0.00%
- Market cap
- 2.97B
- P/E (TTM)i
- 28.26
- P/Bi
- 7.57
- EPSi
- 2.61
- Div yieldi
- 1.30%
- 52W posi
- 42%
Reader sentiment
Are you bullish or bearish on SII?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 12.39, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +59.57% YoY
Margins
- Gross margin
- 37.38%
- Operating margin
- 29.58%
- Net margin
- 25.06%
Key ratios & quality
- PEG ratioi
- 0.50
- Altman Z-Scorei
- 12.39
PEG uses trailing P/E against the 3-year net income growth rate (56.32%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 80.23M | 73.49M | 121.78M | 164.65M | 145.18M | 151.37M | 178.66M | 285.08M |
| Gross profit | 44.08M | 38.67M | 56.82M | 78.48M | 66.62M | 57.58M | 89.73M | 100.46M |
| Selling & admin expenses | 21.73M | 13.56M | 13.74M | 14.70M | 15.98M | 16.56M | 18.77M | 18.48M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 20.04M | 20.46M | 39.02M | 59.23M | 47.29M | 38.18M | 68.74M | 79.50M |
| Pretax profit | 23.98M | 12.95M | 34.66M | 45.19M | 25.08M | 50.29M | 69.01M | 90.36M |
| Tax | 938.31K | 2.74M | 7.68M | 12.01M | 7.45M | 8.49M | 19.71M | 23.01M |
| Net profit | 23.04M | 10.21M | 26.98M | 33.19M | 17.63M | 41.80M | 49.29M | 67.35M |
| Basic EPS | 1 | 0 | 1 | 1 | 1 | 2 | 2 | 3 |
| Diluted EPS | 0.88 | 0.40 | 1.05 | 1.28 | 0.67 | 1.60 | 1.91 | 2.61 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 43.36M | 65.17M | 65.11M | 111.43M | 142.95M | 80.22M |
| Gross profit | 19.57M | 24.89M | 14.74M | 41.27M | 47.31M | 50.56M |
| Selling & admin expenses | 4.13M | 4.83M | 4.47M | 5.05M | 5.86M | 5.09M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 14.90M | 19.43M | 9.62M | 35.56M | 40.76M | 44.80M |
| Pretax profit | 15.75M | 18.86M | 17.27M | 38.48M | 41.94M | 46.23M |
| Tax | 3.80M | 5.36M | 4.11M | 9.75M | 12.72M | 11.97M |
| Net profit | 11.96M | 13.50M | 13.16M | 28.73M | 29.22M | 34.26M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.46 | 0.52 | 0.51 | 1.11 | 1.13 | 1.33 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 81.38M | 95.34M | 85.31M | 77.53M | 76.96M | 45.06M | 79.19M | 187.74M |
| Cash & ST investments | 54.22M | 72.24M | 53.58M | 55.94M | 55.03M | 22.89M | 47.06M | 124.08M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 321.25M | 324.94M | 377.35M | 365.87M | 383.75M | 378.84M | 388.80M | 525.78M |
| Total current liabilities | 39.68M | 35.17M | 47.24M | 28.12M | 25.75M | 21.45M | 30.28M | 97.54M |
| Short-term debt | -- | 3.83M | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | 11.49M | 16.99M | 29.77M | 54.44M | 24.24M | -- | -- |
| Total liabilities | 47,737,000.00 | 53,313,000.00 | 86,365,000.00 | 74,654,000.00 | 106,477,000.00 | 73,130,000.00 | 65,150,000.00 | 158,534,000.00 |
| Total equity | 273.51M | 271.63M | 290.98M | 291.22M | 277.27M | 305.71M | 323.65M | 367.25M |
| Retained earnings | -95.42M | -108.22M | -104.48M | -97.01M | -105.31M | -89.40M | -67.26M | -33.45M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 77.52M | 108.48M | 123.55M | 187.74M | 197.00M | 212.22M |
| Cash & ST investments | 56.11M | 75.38M | 80.34M | 124.08M | 174.57M | 190.50M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 386.13M | 439.43M | 466.17M | 525.78M | 504.27M | 515.76M |
| Total current liabilities | 22.34M | 42.82M | 57.82M | 97.54M | 61.82M | 61.81M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 59,986,000.00 | 93,955,000.00 | 121,441,000.00 | 158,534,000.00 | 124,225,000.00 | 123,575,000.00 |
| Total equity | 326.15M | 345.47M | 344.73M | 367.25M | 380.05M | 392.18M |
| Retained earnings | -63.04M | -57.28M | -51.86M | -33.45M | -14.55M | 9.40M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 66.82M | 33.05M | 26.24M | 51.25M | 32.50M | 29.86M | 69.15M | 97.69M |
| Depreciation & amortization | 1.61M | 3.80M | 4.05M | 4.55M | 3.36M | 2.84M | 2.22M | 2.48M |
| Free cash flow | -23.87M | 30.83M | 25.55M | 50.55M | 32.37M | 28.33M | 67.28M | 95.84M |
| Dividends paid | -21.47M | -22.86M | -23.10M | -25.56M | -25.78M | -25.85M | -27.15M | -33.54M |
| Stock buybacks / issuance | 0 | -1.72M | -2.02M | 0 | -3.04M | -4.16M | -2.02M | -1.55M |
| Ending cash balance | 34.69M | 54.75M | 44.11M | 49.81M | 51.68M | 20.66M | 46.83M | 123.44M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 14.14M | 21.62M | 10.01M | 51.92M | 44.36M | 35.45M |
| Depreciation & amortization | 541.00K | 637.00K | 647.00K | 652.00K | 689.00K | 673.00K |
| Free cash flow | 13.55M | 21.10M | 9.60M | 51.60M | 43.82M | 34.65M |
| Dividends paid | -7.74M | -7.74M | -7.74M | -10.32M | -10.32M | -10.31M |
| Stock buybacks / issuance | -552.00K | 0 | -1.00M | 0 | -500.00K | -6.00M |
| Ending cash balance | 55.87M | 75.08M | 79.90M | 123.44M | 173.93M | 189.82M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.42 | 3.80 | 9.59 | 11.40 | 6.20 | 14.34 | 15.67 | 19.50 |
| ROA %i | 7.20 | 3.24 | 7.68 | 8.93 | 4.70 | 10.96 | 12.84 | 14.73 |
| ROIC %i | 8.24 | 3.88 | 9.46 | 10.82 | 6.03 | 13.65 | 16.37 | 19.76 |
| 5-year avg ROE %i | 4.71 | 4.58 | 8.34 | 8.84 | 7.87 | 9.06 | 11.44 | 13.42 |
| EBIT margin %i | 26.63 | 18.89 | 31.38 | 28.10 | 18.15 | 37.15 | 42.83 | 34.07 |
| FCF / sales %i | -- | 39.50 | 11.41 | 30.65 | 20.98 | 19.36 | 39.97 | 35.66 |
| Current ratioi | 2.05 | 2.71 | 1.81 | 2.76 | 2.99 | 2.10 | 2.62 | 1.92 |
| Quick ratioi | 1.85 | 2.34 | 1.61 | 2.52 | 2.65 | 1.47 | 2.13 | 1.78 |
| Debt / assetsi | -- | 4.71 | 4.50 | 8.14 | 14.19 | 6.40 | -- | -- |
| LT debt / equityi | -- | 4.23 | 5.84 | 10.22 | 19.63 | 7.93 | -- | -- |
| Interest coveragei | -- | 13.49 | 29.02 | 39.92 | 9.58 | 13.39 | 23.32 | 74.94 |
| Revenue CAGR (3Y) %i | -2.48 | -9.43 | 7.93 | 30.92 | 27.80 | 7.33 | 2.43 | 20.33 |
| Net income CAGR (3Y) %i | -- | -24.22 | -3.31 | 12.94 | 19.98 | 15.71 | 14.10 | 56.32 |
| FCF CAGR (3Y) %i | -- | 2.11 | -14.34 | -- | 1.64 | 3.49 | 10.00 | 43.60 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 15.69 | 15.07 | 14.90 | 19.50 | 23.96 | 28.57 |
| ROA %i | 12.81 | 11.79 | 11.45 | 14.73 | 19.00 | 22.06 |
| ROIC %i | 16.26 | 15.53 | 15.22 | 19.76 | 24.22 | 28.81 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 42.20 | 38.43 | 35.08 | 34.07 | 31.92 | 37.58 |
| FCF / sales %i | 40.97 | 44.02 | 35.54 | 35.66 | 34.18 | 36.16 |
| Current ratioi | 3.47 | 2.53 | 2.14 | 1.92 | 3.19 | 3.43 |
| Quick ratioi | 2.88 | 2.21 | 1.90 | 1.78 | 2.98 | 3.28 |
| Debt / assetsi | -- | -- | -- | -- | -- | -- |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 28.33 | 33.91 | 48.48 | 74.94 | 94.76 | 116.32 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Exchange Listed Products is the largest reported line at 76.58% of revenue, across 5 reported segments.
- The next-largest line, Managed Equities, is a distant second at 16.74% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Exchange Listed Products76.58%
Managed Equities16.74%
Private strategies5.47%
Corporate1.03%
Consolidation, elimination and all other segments0.18%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.